financetom
Business
financetom
/
Business
/
Merit Medical Systems Insider Sold Shares Worth $1,423,219, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merit Medical Systems Insider Sold Shares Worth $1,423,219, According to a Recent SEC Filing
Jun 18, 2025 1:21 AM

04:12 AM EDT, 06/18/2025 (MT Newswires) -- Raul Parra Jr., Chief Financial Officer and Treasurer, on June 13, 2025, sold 15,181 shares in Merit Medical Systems ( MMSI ) for $1,423,219. Following the Form 4 filing with the SEC, Parra has control over a total of 26,937 common shares of the company, with 24,201 shares held directly and 2,736 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/856982/000141588925017578/xslF345X05/form4-06172025_090607.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Clearmind Medicine Enrolls First Patient in Study of Potential Alcohol Abuse Treatment
Clearmind Medicine Enrolls First Patient in Study of Potential Alcohol Abuse Treatment
Jun 5, 2025
08:00 AM EDT, 06/05/2025 (MT Newswires) -- Clearmind Medicine ( CMND ) said it has enrolled the first patient for its phase 1/2a clinical trial of CMND-100, an oral drug candidate aimed at treating alcohol use disorder. The trial is aimed at assessing the safety, tolerability, and pharmacokinetic effects of CMND-100 in potentially reducing alcohol cravings and consumption, the clinical-stage...
Regenxbio Reports 'Positive' Interim Data From Duchenne Muscular Dystrophy Trial
Regenxbio Reports 'Positive' Interim Data From Duchenne Muscular Dystrophy Trial
Jun 5, 2025
08:00 AM EDT, 06/05/2025 (MT Newswires) -- Regenxbio ( RGNX ) said Thursday that new interim data from a phase I/II trial of its experimental RGX-202 gene therapy for Duchenne muscular dystrophy showed positive functional, safety and biomarker results. At the same dose being used in the pivotal trial, RGX-202 participants exceeded natural history across all key measures, including the...
MediPharm Labs Closes $4.5 Million Sale of Hope Facility,  to Expand EU GMP Capacity at Napanee
MediPharm Labs Closes $4.5 Million Sale of Hope Facility, to Expand EU GMP Capacity at Napanee
Jun 5, 2025
08:00 AM EDT, 06/05/2025 (MT Newswires) -- MediPharm Labs ( MEDIF ) on Thursday said it has closed the sale of its Hope, British Columbia facility to Rubicon Organics ( ROMJF ) for $4.5 million in cash. The facility was acquired as part of its VIVO Cannabis acquisition in 2023. MediPharm ( MEDIF ) ceased all Hope Facility activities in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved